自动乳腺容积扫描与传统超声、钼靶及MRI评估新辅助治疗后乳腺癌残留病灶的比较
该前瞻性研究纳入156例接受新辅助治疗的乳腺癌患者(159个肿瘤),比较手持超声、钼靶、MRI和自动乳腺容积扫描(ABVS)评估残留肿瘤大小的准确性。ABVS与病理残留肿瘤大小呈中度相关(ICC=0.666),在三阳性肿瘤中一致性较高(ICC=0.797);以5mm为阈值,ABVS与病理尺寸的符合率(64.7%)显著高于超声、钼靶和MRI。ABVS预测病理完全缓解的AUC较高,除与钼靶比较外无统计学差异。
要点
- ABVS与病理残留肿瘤大小中度相关,三阳性乳腺癌中一致性更高。
- 以5mm为阈值,ABVS与病理尺寸符合率显著优于超声、钼靶和MRI。
- ABVS预测pCR的AUC较高,除与钼靶比较外无统计学差异。
关键影像表现/征象
- ABVS与病理残留肿瘤大小的ICC为0.666,呈中度相关。
- 三阳性肿瘤中ABVS与病理的一致性较高,ICC为0.797。
诊断标准与关键数值
- 以5mm为阈值,ABVS与病理尺寸的符合率为64.7%,显著高于超声(50%)、钼靶(45.1%)和MRI(41.4%),P值分别为0.009、0.001和<0.001。
- 预测pCR的ROC曲线下面积:ABVS为0.855,超声为0.816,MRI为0.819,钼靶为0.788;以ABVS为参照,与超声比较P=0.183,与钼靶比较P=0.044,与MRI比较P=0.397。
临床应用与阅片要点
- ABVS可作为新辅助治疗后评估残留病灶的补充手段,尤其在三阳性乳腺癌中一致性较高。
- 以5mm为阈值时ABVS与病理尺寸符合率优于传统超声、钼靶和MRI,阅片时需注意测量最长径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To compare the accuracy of hand-held ultrasonography (US), mammography (MG), magnetic resonance imaging (MRI), and automated breast volume scanning (ABVS) in defining residual breast cancer tumour size after neoadjuvant therapy (NAT).
MATERIALS AND METHODS: Patients diagnosed breast cancer and who received NAT at the Breast Center, Peking University People's Hospital, were enrolled prospectively. Imaging was performed after the last cycle of NAT. The residual tumour size, intraclass correlation coefficients (ICCs), and receiver operating characteristic (ROC) to predict pathological complete response (pCR) were analysed.
RESULTS: A total of 156 patients with 159 tumours were analysed. ABVS had a moderate correlation with histopathology residual tumour size (ICC = 0.666), and showed high agreement among triple-positive tumours (ICC = 0.797). With 5 mm as the threshold, the coincidence rate reached 64.7% between ABVS and pathological size, which was significantly higher than that between US, MG, MRI, and pathological size (50%, 45.1%, 41.4%; p=0.009, p=0.001, p<0.001, respectively). For ROC analysis, ABVS demonstrated a higher area under the ROC curve, but with no statistical difference, except for MG (0.855, 0.816, 0.819, and 0.788, respectively; p=0.183 for US, p=0.044 for MG, and p=0.397 for MRI, with ABVS as the reference).
CONCLUSIONS: The longest tumour diameter on ABVS had a moderate correlation with pathological residual invasive tumour size. ABVS was shown to have good ability to predict pCR and would appear to be a potential useful tool for the assessment after NAT for breast cancer.
引用
- Peng, Yuan, Xie, et al. Comparison of automated breast volume scanning with conventional ultrasonography, mammography, and MRI to assess residual breast cancer after neoadjuvant therapy by molecular type. Clin Radiol. 2023. PMID: 36822980. doi:10.1016/j.crad.2022.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。